How much funding has Veradermics, Incorporated raised?

Veradermics, Incorporated has raised $412.2M in total funding, most recently a series c round.

When was Veradermics, Incorporated founded?

Veradermics, Incorporated was founded in 2019.

Where is Veradermics, Incorporated headquartered?

Veradermics, Incorporated is headquartered in New Haven, Connecticut, United States.

What industry is Veradermics, Incorporated in?

Veradermics, Incorporated operates in Biotech, Healthcare.

How many employees does Veradermics, Incorporated have?

Veradermics, Incorporated has 1-10 employees.

Veradermics, Incorporated

Q: Who are Veradermics, Incorporated's investors?

Veradermics, Incorporated's investors include SR One, Suvretta Capital Management, OrbiMed, Viking Global, Marshall Wace.

IPO

Dermatology and Aesthetics Solutions | Veradermics

Public · New Haven, United States · Founded 2019 · $412.2M raised

Biotech

Healthcare

Headquarters: New Haven, Connecticut
Employees: 1–10
Founded: 2019
Business Model: B2B
Website: veradermics.com

Total Funding: $412.2M
Last Round: $150.0M Series COct 2025
Rounds: 5
Type: Public

About

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company headquartered in New Haven, Connecticut, developing innovative therapeutics for pattern hair loss. Its lead asset, VDPHL01, is a potential non-hormonal oral treatment advancing through Phase 3 trials, including the first ever US trial for female pattern hair loss. The company listed on the NYSE under ticker MANE.

Summary

Veradermics, Incorporated is a Biotech company based in New Haven, United States, founded in 2019. It has raised $412.2M in total across 5 rounds, most recently a $150.0M Series C round in Oct 2025. Investors include SR One, Suvretta Capital Management and OrbiMed.

LinkedIn X (Twitter)